Form 4: Karyopharm Therapeutics Executive Sells Shares
Insider Transaction (Form 4)
Kristin Abate, Chief Accounting Officer of Karyopharm Therapeutics Inc., sold 378 shares of common stock on October 1, 2026 for $1.19 per share.
Summary
- Open-market sale: disposed of 378 Common Stock at $1.19 ($450) on October 1, 2026; holds 23,404 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $450 of stock on the open market.
Insider Transactions
Kristin Abate — Officer (Chief Accounting Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-01 | Open-market sale | Common Stock | 378 | $1 | $450 | 23,404 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-01 | Open-market sale (378 shares) |
Keywords
insider transaction, Form 4, KPTI, Karyopharm Therapeutics Inc., bearish, Kristin Abate
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.